The abdomen typically provides the most consistent absorption for subcutaneous injections, though all approved sites are clinically effective when proper technique is used
Insulin is the preferred agent for management due to the lack of long-term safety data for noninsulin agents
Recent research has shown promising results of Semaglutide GLP-1 use in non-diabetic individuals for weight management
This may involve adjusting the Ozempic dosage, adopting a more gradual weight loss plan, or exploring alternative weight management strategies. After significant weight loss, she explains, the skin needs time to adjust and may return to a more natural state on its own
However, the drugs are not entirely risk-free, with roughly one in 10 GLP-1 users experiencing side effects such as nausea, vomiting, diarrhea and constipation
What are GLP1-RAs